IRLAB Therapeutics (Sweden) Math Transform Price Floor Movement

IRLAB-A Stock

SEK 1.59 0.01 0.63%

The math transform view organizes Price Floor Movement transformation and supporting indicators around IRLAB Therapeutics. This view tracks price transformations that reveal shifts in trend structure to support structured performance interpretation without implying advice.

Symbol

Transformation

This analysis covers sixty-one data points across the selected time horizon. IRLAB Therapeutics Price Floor Movement function is a real number to the smallest following price integer.

IRLAB Therapeutics Technical Analysis Modules

Most technical analysis of IRLAB Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for IRLAB from various momentum indicators to cycle indicators. When you analyze IRLAB charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

IRLAB Therapeutics AB operates as a drug discovery and development company that provides drugs in the field of neurological and neuropsychiatric disorders. Its pipeline candidates include IRL790, a psychomotor stabilizer for the treatment of L-dopa induced dyskinesias in Parkinsons disease and Parkinson disease psychosis IRL752, a cortical enhancer for the treatment of Parkinson disease dementia and behavioral and psychological symptoms of dementia IRL626, a fast-off D2 antagonist for use in the treatment of schizophrenia P001, a cortical enhancer program for the treatment of attention disorders and IRL448IRL555, a followup Parkinsons disease program. IRLAB Therapeutics is traded on Stockholm Stock Exchange in Sweden. The stock overview for IRLAB Therapeutics summarizes business drivers, financial profile, and market behavior. Current metrics include P/B of 6.24, profit margin of -1.69%. IRLAB Therapeutics has a market cap of 525.71 M, ROE of -27.69%.

Methodology

Unless otherwise specified, financial data for IRLAB Therapeutics AB is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. IRLAB (SE:IRLAB-A) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report is built using public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR. Normalization for analytical consistency may introduce small timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

IRLAB Therapeutics AB may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Vlad Skutelnik - Macroaxis Contributor

Last reviewed on March 14th, 2026

Align your values with your investing style

At 525.71 Million in the Biotechnology space, IRLAB Therapeutics AB smaller-cap profile gives investors a structured starting point for building sector-aligned themes. IRLAB Therapeutics AB smaller-cap scale (525.71 Million) within Biotechnology helps compare substitutes, complements, and diversifiers that strengthen the overall Healthcare allocation.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Driverless Cars Invested few shares	Go
	Macroaxis Index Invested over 60 shares	Go
	Adviser Favorites Invested few shares	Go
	Warren Buffett Holdings Invested over 20 shares	Go
	Artificial Intelligence Invested few shares	Go
	Advertising Invested few shares	Go
	Momentum Invested few shares	Go
	Hedge Favorites Invested over 20 shares	Go

More Resources for IRLAB Stock Analysis

Other Information on Investing in IRLAB Stock

IRLAB Therapeutics financial ratios provide valuation context across profits, cash flow, and enterprise value. They help compare IRLAB across valuation measures and peers.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC